295
Participants
Start Date
December 14, 2020
Primary Completion Date
October 5, 2022
Study Completion Date
May 10, 2023
RTH258/Brolucizumab
Brolucizumab is a new generation of anti-VEGF (vascular endothelial growth factor). All patients will be treated with brolucizumab 6mg: 3 loading injections (at Screening/Baseline, Week 4 and Week 8), followed by Treat-to-Control regimen up to Week 44/46.
Novartis Investigative Site, Marseille
Novartis Investigative Site, Aix-en-Provence
Novartis Investigative Site, Caen
Novartis Investigative Site, Caen
Novartis Investigative Site, La Rochelle
Novartis Investigative Site, Dijon
Novartis Investigative Site, Plérin
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Saint-Jean
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Saint-Jean-de-Védas
Novartis Investigative Site, Rennes
Novartis Investigative Site, Tours
Novartis Investigative Site, Saint-Cyr-sur-Loire
Novartis Investigative Site, Grenoble
Novartis Investigative Site, Nantes
Novartis Investigative Site, Nantes
Novartis Investigative Site, Saint-Herblain
Novartis Investigative Site, Montargis
Novartis Investigative Site, Angers
Novartis Investigative Site, Saint-Martin-des-Champs
Novartis Investigative Site, Lille
Novartis Investigative Site, Perpignan
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Colmar
Novartis Investigative Site, Mulhouse
Novartis Investigative Site, Lyon
Novartis Investigative Site, Lyon
Novartis Investigative Site, Lyon
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Rouen
Novartis Investigative Site, Melun
Novartis Investigative Site, Le Chesnay
Novartis Investigative Site, Montauban
Novartis Investigative Site, La Valette-du-Var
Novartis Investigative Site, Avignon
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Rueil-Malmaison
Novartis Investigative Site, Bobigny
Novartis Investigative Site, Créteil
Novartis Investigative Site, Vincennes
Novartis Investigative Site, Nice
Novartis Investigative Site, Marseille
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY